Search - tctmd.com

Displaying 301 - 320 of 362

Sort: Relevancy | Date

Presentation TCT 2013

TCT-46. Effects of Radial versus Femoral Accesses for Percutaneous Coronary Interventions in Octogerians with Acute Coronary Syndromes

Presenter: Elmir Omerovic

October 29, 2013

Presentation TCT 2013

TCT-44. Impact of arterial access on all cause mortality in octogenarians, following Primary Percutaneous Intervention (PPCI) for ST elevation myocardial infarction (STEMI):...

Presenter: Albert Alahmar

October 29, 2013

News Daily News

Weekend vs. Weekday Admission Carries No Added Risk for NSTE ACS Patients

Caitlin E. Cox

October 25, 2013

News Daily News

Los Ingresos Hospitalarios en Días Laborales frente a Fin de Semana No acarrean Más Riesgos para Pacientes SCASEST

Caitlin E. Cox

October 25, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

INFUSE-AMI: El Descenso del Tamaño del Infarto a los 30 Días podría Traducirse en Beneficios al cabo de 1 Años

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

News Daily News

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

July 05, 2013

News Daily News

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

July 05, 2013

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

News Conference News ACC 2013

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Caitlin E. Cox

March 12, 2013

News Daily News

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

February 27, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Daily News

TROFI Published: No Clear Benefit of Thrombectomy in STEMI Patients Undergoing PCI

L.A. McKeown

February 12, 2013

News Daily News

TROFI Publicado: La Trombectomía No arroja un Beneficio Claro en Pacientes STEMI sometidos a PCI

L.A. McKeown

February 12, 2013

News Daily News

PCI Reduces In-Hospital Mortality in Nonagenarians with STEMI

Yael L. Maxwell

January 31, 2013

News Daily News

La PCI Reduce la Mortalidad Intra Hospitalaria en Nonagenarios víctimas de STEMI

Yael L. Maxwell

January 31, 2013

Advertisement

TCT-46. Effects of Radial versus Femoral Accesses for Percutaneous Coronary Interventions in Octogerians with Acute Coronary Syndromes

TCT-44. Impact of arterial access on all cause mortality in octogenarians, following Primary Percutaneous Intervention (PPCI) for ST elevation myocardial infarction (STEMI):...

Weekend vs. Weekday Admission Carries No Added Risk for NSTE ACS Patients

Los Ingresos Hospitalarios en Días Laborales frente a Fin de Semana No acarrean Más Riesgos para Pacientes SCASEST

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

INFUSE-AMI: El Descenso del Tamaño del Infarto a los 30 Días podría Traducirse en Beneficios al cabo de 1 Años

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

TROFI Published: No Clear Benefit of Thrombectomy in STEMI Patients Undergoing PCI

TROFI Publicado: La Trombectomía No arroja un Beneficio Claro en Pacientes STEMI sometidos a PCI

PCI Reduces In-Hospital Mortality in Nonagenarians with STEMI

La PCI Reduce la Mortalidad Intra Hospitalaria en Nonagenarios víctimas de STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content